Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

House dust mite allergy vaccine - Allergopharma

Next Previous
Drug Profile

House dust mite allergy vaccine - Allergopharma

Alternative Names: Acaroid; Dermatophagoides pteronyssinus allergoids

Latest Information Update: 25 Jan 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Allergopharma
  • Class Allergens; Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic asthma; Allergic rhinitis; Allergic rhinoconjunctivitis

Most Recent Events

  • 23 Dec 2016 Allergopharma initiates a phase III trial for Allergic asthma, Allergic rhinitis and Allergic rhinoconjunctivitis in Spain (SC) (EudraCT2015-000188-15)
  • 07 Mar 2012 Phase-II clinical trials in Allergic asthma in Poland (SC) (EudraCT 2011-002248-29)
  • 07 Mar 2012 Allergopharma Joachim Ganzer KG initiates enrolment in a phase II trial for Allergic asthma in Poland (EudraCT 2011-002248-29)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top